Detalhe da pesquisa
1.
Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.
Gynecol Oncol
; 181: 162-169, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38211393
2.
Pharmacokinetics of neratinib during coadministration with lansoprazole in healthy subjects.
Br J Clin Pharmacol
; 83(3): 554-561, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27628584
3.
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer.
Breast
; 67: 94-101, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702070
4.
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.
Eur J Cancer
; 184: 48-59, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898233
5.
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.
Nat Commun
; 14(1): 630, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746967